AAR
Beyond's analysis on AAR
Recent news mentioning AAR
- — Ondo lanceert 'Intelligent Portfolios', mogelijk gemaakt door BlackRock, waarmee portefeuillestrategieën op de blockchain worden gebracht
- — Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
- — Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
- — AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class Action, Encourages Investors with Losses to Contact the Firm
- — SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in Aardvark Therapeutics, Inc. Lawsuit - AARD
- — Konsum: Milliardengeschäft – wie Henkel dank seiner Haarsparte wächst
- — Konsum: Milliardengeschäft – wie Henkel dank seiner Haarsparte wächst
- — SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of STAAR Surgical Company (NASDAQ: STAA).
- — Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadline
- — Kuehn Law Encourages Investors of Aardvark Therapeutics, Inc. to Contact Law Firm
- — 2XU Strengthens North American Leadership with Appointment of Aaron Brown
- — Levi & Korsinsky Reminds Aardvark Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 13, 2026 - AARD
Browse the full archive →